Medical Patent News

RSS

PDL BioPharma and Alexion Pharmaceuticals resolve patent dispute

PDL BioPharma, Inc. and Alexion Pharmaceuticals, Inc. today jointly announced that the companies have entered into a definitive license agreement and settlement agreement that resolve the legal disputes between them relating to Alexion's humanized antibody, Soliris (eculizumab) and PDL's patents known as the Queen et al. patents.

5 Jan 2009

Human Pheromone Sciences files patent for mood enhancing compound derived from sea coral

Human Pheromone Sciences, Inc. has announced that it has filed a Comprehensive Patent Application with the U.S. Patent and Trademark Office for the use of an innovative and previously undeveloped compound with its origin in sea coral, which has significant emotional impacts on both men and women, enhancing feelings of positive social relationships, personal well-being and social attraction.

17 Dec 2008

Nutraceutix issued Australian patent

The Australian Patent Office has issued Nutraceutix, Inc. a patent for BIO-tract.

16 Dec 2008

Epeius Biotechnologies awarded European patents for targeted genetic anti-cancer medicine

Epeius Biotechnologies Corporation has received two additional European patents for the platform targeting technologies and molecular designs that enable precision gene delivery to primary cancers and metastatic lesions that have spread throughout the body.

16 Dec 2008

PreMD files provisional patent application for new method of quantifying cancer biomarkers

Predictive medicine company PreMD Inc. has announced that it has filed a provisional patent application that describes a new simplified method of quantifying immunohistochemical staining of biomarkers. The provisional patent application was filed with the United States Patent and Trademark office.

11 Dec 2008

Labcyte awarded U.S. patent for transferring liquids within sealed containers

Labcyte Inc. announces the issuance of U.S. Patent 7,405,072, which uses the unique advantages of moving liquids with sound to transfer fluids within a sealed container, free from any physical contact. This process can be applied to the testing of pathogens and other dangerous fluids.

10 Dec 2008

Intralytix awarded U.S. patent for bacteriophage treatment of colonization by pathogenic bacteria

Intralytix, Inc., announced today that it has been issued a patent by the U.S. Patent & Trademark Office covering the use of bacteriophages to reduce the risk of bacterial infection in persons colonized with pathogenic bacteria including MRSA.

10 Dec 2008

Aperio Technologies receives another patent for TDI arrays in microscope slide scanners

Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, announced today that the United States Patent and Trademark Office has issued the company patent No. 7,457,446 entitled "Fully Automatic Rapid Microscope Slide Scanner."

10 Dec 2008

Alnylam Pharmaceuticals update on Kreutzer-Limmer patent estate

Alnylam Pharmaceuticals, Inc. has announced that the European Patent Office (EPO) has ruled in favor of the Appellants in oral proceedings before the Board of Appeals related to the '623 (EP 1144623) patent in its Kreutzer-Limmer patent estate.

10 Dec 2008

Intradigm issued new RNAi therapeutics patent

Intradigm Corporation has announced the issuance of United States patent 7,459,547, entitled "Methods and Compositions for Controlling Efficacy of RNA Silencing."

3 Dec 2008

Aduromed Industries files patent application for containerized medical waste treatment system

Aduromed Industries, Inc. has announced that it successfully filed a U.S. patent on November 24, 2008 to protect the Company's proprietary technology for its new standard, containerized MedClean Systems that provide a turnkey solution for onsite regulated medical waste sterilization and volume reduction.

3 Dec 2008

Mylan confirms first-to-file patent challenge of AMRIX capsules

Mylan Inc. has confirmed that the company and its subsidiary, Mylan Pharmaceuticals Inc., have been sued by Cephalon Inc., Eurand Inc. and Anesta AG in connection with the filing of an Abbreviated New Drug Application (ANDA) for Cyclobenzaprine Hydrochloride (HCl) Extended-release (ER) Capsules, 15 mg and 30 mg, the generic version of AMRIX Capsules.

1 Dec 2008

Barr Labs confirms patent challenge of Amrix extended-release capsules

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Anesta in connection with its Amrix (cyclobenzaprine hydrochloride) extended-release capsules, 15mg and 30mg.

26 Nov 2008

Teva announces agreement on generic Pulmicort Respules patent challenge

Teva Pharmaceutical Industries Ltd. has announced that its subsidiary, Teva Pharmaceuticals USA, Inc., has signed an agreement with AstraZeneca to settle patent litigation involving Teva's U.S. generic version of AstraZeneca's Pulmicort (Budesonide) Respules including all claims for patent infringement and damages.

25 Nov 2008

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

Peregrine Pharmaceuticals, Inc. has announced that the U.S. Patent and Trademark Office has issued U.S. Patent Number No. 7,455,833, which includes broad claims covering anti-viral applications of antibodies that directly bind to aminophospholipids.

25 Nov 2008

AstraZeneca settles U.S. Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals

AstraZeneca has announced it has entered into a settlement agreement in its Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals, Inc., a wholly owned subsidiary of Teva Pharmaceuticals USA.

25 Nov 2008

MorphoSys granted U.S. patent on antibodies against GM-CSF to treat inflammatory disorders

MorphoSys AG and the University of Melbourne announced today that the U.S. Patent & Trademark Office (USPTO) has confirmed that it will issue U.S. Patent No. 7,455,836, covering key uses of antibodies against GM-CSF.

25 Nov 2008

USPTO confirms validity of Bystolic patent

Forest Laboratories, Inc. announced today that the U.S. Patent and Trademark Office ("USPTO") has closed prosecution on the merits of the reexamination proceedings for the patent for Bystolic and confirmed the validity of all of the previously granted claims.

24 Nov 2008

Brookhaven scientists receive patent for improved cancer therapy device

Four physicists at the U.S. Department of Energy's (DOE) Brookhaven National Laboratory have been awarded U.S. Patent No. 7,432,516 B2 for the design of a "medical synchrotron" capable of delivering precision doses of proton radiation to cancerous tumors with minimal damage to surrounding healthy tissue.

24 Nov 2008

Barr announces agreements on Nasacort AQ, Allegra D-12 and Allegra patent challenges

Barr Pharmaceuticals, Inc. today announced that its subsidiary, Barr Laboratories, Inc. has entered into separate settlement agreements related to ongoing patent challenges for Nasacort AQ (triamcinolone acetonide) nasal spray, Allegra D-12 Hour (fexofenadine hydrochloride 60mg and pseudoephedrine hydrochloride 120mg) extended-release tablets, and Allegra (fexofenadine) 30mg, 60mg and 180mg tablets.

19 Nov 2008

Medical Patent News

PDL BioPharma and Alexion Pharmaceuticals resolve patent dispute

Human Pheromone Sciences files patent for mood enhancing compound derived from sea coral

Nutraceutix issued Australian patent

Epeius Biotechnologies awarded European patents for targeted genetic anti-cancer medicine

PreMD files provisional patent application for new method of quantifying cancer biomarkers

Labcyte awarded U.S. patent for transferring liquids within sealed containers

Intralytix awarded U.S. patent for bacteriophage treatment of colonization by pathogenic bacteria

Aperio Technologies receives another patent for TDI arrays in microscope slide scanners

Alnylam Pharmaceuticals update on Kreutzer-Limmer patent estate

Intradigm issued new RNAi therapeutics patent

Aduromed Industries files patent application for containerized medical waste treatment system

Mylan confirms first-to-file patent challenge of AMRIX capsules

Barr Labs confirms patent challenge of Amrix extended-release capsules

Teva announces agreement on generic Pulmicort Respules patent challenge

Peregrine Pharmaceuticals awarded U.S. patent for anti-viral applications of phospholipid-targeting antibodies

AstraZeneca settles U.S. Pulmicort Respules patent infringement litigation against Ivax Pharmaceuticals

MorphoSys granted U.S. patent on antibodies against GM-CSF to treat inflammatory disorders

USPTO confirms validity of Bystolic patent

Brookhaven scientists receive patent for improved cancer therapy device

Barr announces agreements on Nasacort AQ, Allegra D-12 and Allegra patent challenges

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News